Amniotic fluid-a source for clinical therapeutics in the newborn?

Stem Cells and Development

Volumn 24, Issue 12, 2015, Pages 1405-1414

  Ekblad, Åsa ^a   Qian, Hong ^a   Westgren, Magnus ^a   Le Blanc, Katarina ^a   Fossum, Magdalena ^a   Gotherstrom, Cecilia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; STEM CELL FACTOR RECEPTOR; LEUKOCYTE ANTIGEN;

AMNION FLUID; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL THERAPY; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGENICITY; NEWBORN; PRIORITY JOURNAL; SENESCENCE; SOFT TISSUE DISEASE; AMNIOCENTESIS; BIOSYNTHESIS; CELL SEPARATION; CONGENITAL ABNORMALITIES; CYTOLOGY; FEMALE; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PREGNANCY;

AMNIOCENTESIS; AMNIOTIC FLUID; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CONGENITAL ABNORMALITIES; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; MESENCHYMAL STROMAL CELLS; PREGNANCY;

EID: 84930451591     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0426     Document Type: Article

References (39)

1. Whiteman VE and EA Reece. (1994). Prenatal diagnosis of major congenital malformations. Curr Opin Obstet Gynecol 6:459-467.
2. McCandless SE, JW Brunger and SB Cassidy. (2004). The burden of genetic disease on inpatient care in a children's hospital. Am J Hum Med Genet 74:121-127.
3. Saxena AK. (2010). Congenital anomalies of soft tissues: birth defects depending on tissue engineering solutions and present advances in regenerative medicine. Tissue Eng Part B Rev 16:455-466.
4. Keidar Z and S Nitecki. (2013). FDG-PET in prosthetic graft infections. Semin Nucl Med 43:396-402.
5. Urita Y, H Komuro, G Chen, M Shinya, R Saihara and M Kaneko. (2008). Evaluation of diaphragmatic hernia repair using PLGA mesh-collagen sponge hybrid scaffold: an experimental study in a rat model. Pediatr Surg Int 24: 1041-1045.
6. Griffith PS, V Valenti, K Qurashi and A Martinez-Isla. (2008). Rejection of goretex mesh used in prosthetic cruroplasty: a case series. Int J Surg 6:106-109.
7. Lewin JS, KA Hutcheson, DA Barringer, LE Croegaert, A Lisec and MS Chambers. (2012). Customization of the voice prosthesis to prevent leakage from the enlarged tracheoesophageal puncture: results of a prospective trial. Laryngoscope 122:1767-1772.
8. Underwood MA, WM Gilbert and MP Sherman. (2005). Amniotic fluid: not just fetal urine anymore. J Perinatol 25:341-348.
9. Sachs L. (1956). Analysis of amniotic fluid cells for diagnosis of foetal sex. Br Med J 2:795-798.
10. Tsai M-S. (2004). Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19:1450-1456.
11. Prusa AR, E Marton, M Rosner, G Bernaschek and M Hengstschlager. (2003). Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18:1489-1493.
12. De Coppi P, G Bartsch, Jr., MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106.
13. Da Sacco S, S Sedrakyan, F Boldrin, S Giuliani, P Parnigotto, R Habibian, D Warburton, RE De Filippo and L Perin. (2010). Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 183:1193-1200.
14. Moschidou D, S Mukherjee, MP Blundell, K Drews, GN Jones, H Abdulrazzak, B Nowakowska, A Phoolchund, K Lay, et al. (2012). Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgenefree approach. Mol Ther 20:1953-1967.
15. Hartmann K, O Raabe, S Wenisch and S Arnhold. (2013). Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retinalike cells. Am J Stem Cells 2:108-118.
16. Kaviani A, TE Perry, A Dzakovic, RW Jennings, MM Ziegler and DO Fauza. (2001). The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36:1662-1665.
17. Weber B, D Kehl, U Bleul, L Behr, S Sammut, L Frese, A Ksiazek, J Achermann, G Stranzinger, et al. (2013). In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med; doi: 10.1002/term.1781.
18. Anker PS, SA Scherjon, C Kleijburg-van der Keur, WA Noort, FH Claas, R Willemze, WE Fibbe and HH Kanhai. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548-1549.
19. Schmidt D, J Achermann, B Odermatt, C Breymann, A Mol, M Genoni, G Zund and SP Hoerstrup. (2007). Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 116:I64-I70.
20. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
21. Odibo AO, DL Gray, JM Dicke, DM Stamilio, GA Macones and JP Crane. (2008). Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol 111:589-595.
22. Jones EA, SE Kinsey, A English, RA Jones, L Straszynski, DM Meredith, AF Markham, A Jack, P Emery and D McGonagle. (2002). Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46:3349-3360.
23. Kuci S, Z Kuci, H Kreyenberg, E Deak, K Putsch, S Huenecke, C Amara, S Koller, E Rettinger, et al. (2010). CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftmentpromoting properties. Haematologica 95:651-659.
24. Roubelakis MG, V Bitsika, D Zagoura, O Trohatou, KI Pappa, M Makridakis, A Antsaklis, A Vlahou and NP Anagnou. (2011). In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med 15:1896-1913.
25. Gucciardo L, N Ochsenbein-Kolble, Y Ozog, G Verbist, V Van Duppen, JP Fryns, R Lories and J Deprest. (2013). A comparative study on culture conditions and routine expansion of amniotic fluid-derived mesenchymal progenitor cells. Fetal Diagn Ther 34:225-235.
26. Zia S, J Toelen, M Mori da Cunha, P Dekoninck, P de Coppi and J Deprest. (2013). Routine clonal expansion of mesenchymal stem cells derived from amniotic fluid for perinatal applications. Prenat Diagn 33:921-928.
27. Zimmerlin L, VS Donnenberg and AD Donnenberg. (2014). Pericytes: a universal adult tissue stem cell? Cytometry A 81:12-14.
28. Lin CS, H Ning, G Lin and TF Lue. (2012). Is CD34 truly a negative marker for mesenchymal stromal cells? Cytotherapy 14:1159-1163.
29. Zhang S, H Geng, H Xie, Q Wu, X Ma, J Zhou and F Chen. (2010). The heterogeneity of cell subtypes from a primary culture of human amniotic fluid. Cell Mol Biol Lett 15:424-439.
30. Davydova DA, EA Vorotelyak, YA Smirnova, RD Zinovieva, YA Romanov, NV Kabaeva, VV Terskikh and AV Vasiliev. (2009). Cell phenotypes in human amniotic fluid. Acta Naturae 1:98-103.
31. Gotherstrom C, O Ringden, M Westgren, C Tammik and K Le Blanc. (2003). Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32:265-272.
32. Gotherstrom C, O Ringden, C Tammik, E Zetterberg, M Westgren and K Le Blanc. (2004). Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190:239-245.
33. Ryden M, A Dicker, C Gotherstrom, G Astrom, C Tammik, P Arner and K Le Blanc. (2003). Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochem Biophys Res Commun 311:391-397.
34. Le Blanc K, C Gotherstrom, O Ringden, M Hassan, R McMahon, E Horwitz, G Anneren, O Axelsson, J Nunn, et al. (2005). Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607-1614.
35. Zhang P, J Baxter, K Vinod, TN Tulenko and PJ Di Muzio. (2009). Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli. Stem Cells Dev 18:1299-1308.
36. Guillot PV, C De Bari, F Dell'Accio, H Kurata, J Polak and NM Fisk. (2008). Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 76:946-957.
37. Bai J, Y Wang, L Liu, J Chen, W Yang, L Gao and Y Wang. (2012). Human amniotic fluid-derived c-kit ( + ) and c-kit (-) stem cells: growth characteristics and some differentiation potential capacities comparison. Cytotechnology 64:577-589.
38. Yu X, N Wang, R Qiang, Q Wan, M Qin, S Chen and H Wang. (2014). Human amniotic fluid stem cells possess the potential to differentiate into primordial follicle oocytes in vitro. Biol Reprod 90:73.
39. Burnet FM. (1974). Intrinsic Mutagenesis, a Genetic Approach to Ageing. J. Wiley, New York, NY.